BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

Biopharma Insights


14 Cutting-Edge Startups Focusing On RNA …

14 Cutting-Edge Startups Focusing On RNA Research

May 29, 2024   by Andrii Buvailo, PhD     Articles
For many years, the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
Continue ›››
Insilico Medicine Unveils nach0: A Comprehensive …

Insilico Medicine Unveils nach0: A Comprehensive LLM for Chemical and Biomedical Applications

May 21, 2024   by Roman Kasianov     Articles
Insilico Medicine, a clinical-stage AI-driven drug discovery company, in collaboration with NVIDIA, has introduced nach0, a novel large language model …
Continue ›››
4 Biotech Startups Developing Breakthrough Drug …

4 Biotech Startups Developing Breakthrough Drug Modalities

May 9, 2024   by Andrii Buvailo, PhD     Articles
In the dynamic world of drug discovery, companies must continually innovate beyond their existing drug portfolios and modalities. Relying solely …
Continue ›››
The Growing Impact of AI in …

The Growing Impact of AI in Healthcare

May 3, 2024   by Andrii Buvailo     Articles
The advent of artificial intelligence (AI) in healthcare has catalyzed an epoch of change, reshaping diagnostic procedures, therapeutic strategies, and …
Continue ›››

Is AI impacting the Life Sciences real estate market?

May 3, 2024   by Travis McCready     Articles
Artificial intelligence (AI) is one of the most disruptive technologies the Life Sciences sector has ever seen. It’s having a …
Continue ›››
From Diagnosis to Treatment: The Impact …

From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development

April 29, 2024   by Louise von Stechow     Articles
Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US …
Continue ›››
Optimising Drug Discovery R&D with Graphs

Optimising Drug Discovery R&D with Graphs

April 29, 2024   by Dr. Alexander Jarasch     Articles
Data in Life Sciences expert Dr Alexander Jarasch on a new wave of advanced data handling techniques that point the …
Continue ›››
A Landscape of AI-discovered Molecules and …

A Landscape of AI-discovered Molecules and Target Novelty Analysis

April 21, 2024     Articles
We have recently launched a report, “It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?” where …
Continue ›››
How Industry Embraces Organ-on-Chips: A 2024 …

How Industry Embraces Organ-on-Chips: A 2024 Status Report

April 17, 2024   by Viraj Mehta     Articles
Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and …
Continue ›››
11 Notable Companies Enabling Decentralized Clinical …

11 Notable Companies Enabling Decentralized Clinical Trials

April 9, 2024   by Bohdana Sokolova     Articles
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
Continue ›››
How AI Empowers Biomarker-Driven Clinical Trials

How AI Empowers Biomarker-Driven Clinical Trials

April 8, 2024   by Andrii Buvailo     Articles
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
Continue ›››
Patented AI Platform Identifies Promising Early-Stage …

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

April 8, 2024   by Dimitrios Skaltsas, Bara Badwan, Panos Karelis     Articles
Sponsored by Intelligencia AI
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.